Baxter International (BAX) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Baxter International (BAX) do?
Baxter International Inc (BAX) is a U.S.-listed company in Healthcare (Medical Instruments & Supplies). What it does: Produces intravenous solutions, drug delivery devices, and kidney care equipment for hospitals and clinics worldwide. Baxter produces essential intravenous fluids, drug delivery pumps, and surgical tools distributed directly to global. It is worth $13.14B on the market and sold $11.62B over the last year.
- Market cap
- $13.14B
- P/E ratio
- None (reported a loss)
- Annual sales
- $11.62B
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Brief updated
- Nov 17, 2026
Brands and businesses behind BAX
- Hillrom: Sells smart hospital beds, patient handling devices, and operating room workflow systems to healthcare providers.
- Welch Allyn: Manufactures physical exam instruments and vital sign diagnostic equipment sold to outpatient clinics and emergency rooms.
- Novum IQ: Provides connected large volume and syringe infusion pumps to administer intravenous medications in hospitals.
- Floseal: Produces a gelatin-based hemostatic matrix applied by surgeons to control active bleeding during operations.
- Tisseel: Supplies fibrin sealant products used by surgical teams to control bleeding and glue tissue in operating suites.
BAX’s flags, in plain English
Each flag is a number from Baxter International’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 17, 2026.
Cheap on Cash Flow
Priced at 11.6 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.
Stupid Cash
Can pay this year's bills 1.8 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Debt Is Driving
Heavy debt, 123% of shareholder equity. The company owes a lot compared with what it earns. Lenders get paid before shareholders, which leaves management fewer options in a weak year.
2 more risk notes open with the free trial. Try it free for 7 days.
Questions about BAX
How big is Baxter International?
Baxter International’s market cap is $13.14B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $11.62B: what customers paid the company over the last year, before any costs.
What is BAX’s P/E ratio?
BAX has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with BAX?
A single facility in North Carolina supplies the majority of domestic intravenous solutions, making operational interruptions a major supply risk. That is one risk on Baxter International’s card. Its first risk flag is Debt Is Driving, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Baxter International’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. BAX’s filings on SEC.gov. The Margin Monkey is research, not advice.
